MedPath

Silver nitrate

Generic Name
Silver nitrate
Brand Names
Styptstix
Drug Type
Small Molecule
Chemical Formula
AgNO3
CAS Number
7761-88-8
Unique Ingredient Identifier
95IT3W8JZE

Overview

Silver nitrate is an inorganic compound with the chemical formula AgNO3. In its solid form, silver nitrate is coordinated in a trigonal planar arrangement. It is often used as a precursor to other silver-containing compounds. It is used in making photographic films, and in laboratory setting as a staining agent in protein visualization in PAGE gels and in scanning electron microscopy.

Indication

1%~2%溶液用于新生儿淋菌性眼炎的预防;0.5%~1%溶液用于结膜炎、沙眼急性期;0.3%溶液制成敷料用于Ⅱ度和清创后的Ⅲ度大面积烧伤,以预防铜绿假单胞菌、变形杆菌和其他革兰阴性菌的感染;10%~20%溶液或硝酸银棒局部使用,用于腐蚀生长过剩肉芽组织及疣。

Associated Conditions

No associated conditions information available.

Research Report

Published: Sep 30, 2025

Comprehensive Monograph: Silver Nitrate (AgNO₃)

1.0 Executive Summary

Silver nitrate () is an inorganic compound with a long and multifaceted history in medicine, valued primarily as a topical anti-infective and chemical cauterizing agent.[1] Its therapeutic utility is derived from the potent, dual-action biological activity of the free silver ion (

), which is released upon dissolution in an aqueous environment.[2] This monograph provides a comprehensive analysis of its chemical properties, pharmacology, clinical applications, toxicology, and regulatory status.

The compound's mechanism of action is twofold. It exerts a broad-spectrum antimicrobial effect against gram-positive and gram-negative bacteria, fungi, and some viruses through multiple pathways, including the disruption of microbial proteins via binding to sulfhydryl groups, the destabilization of cell membranes, and the inhibition of DNA replication.[3] Concurrently, its caustic action on mammalian tissue results from the coagulation of cellular proteins to form a protective eschar. This process facilitates chemical debridement and provides effective hemostasis for minor capillary bleeding.[3]

Primary clinical applications are focused on topical treatments where both antimicrobial and caustic effects are desired. These include the cauterization of wounds, management of hypergranulation tissue, treatment of ulcers, control of epistaxis, and the removal of verrucae (warts) and skin tags.[7]

Continue reading the full research report

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2025/02/20
Not Applicable
Completed
Youssef Zaki
2024/11/08
Phase 2
Not yet recruiting
Francesco Egro
2024/10/08
Not Applicable
Recruiting
2024/04/12
Phase 2
Completed
Children Hospital and Institute of Child Health, Lahore
2020/09/23
Phase 4
Completed
Umraniye Education and Research Hospital
2018/12/20
Phase 1
UNKNOWN
2015/11/13
Early Phase 1
Completed
Arwa Owais
2015/08/11
Phase 3
Terminated
2015/03/25
Phase 4
UNKNOWN
2014/04/17
Phase 4
Completed

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
Boiron
0220-0457
ORAL
6 [hp_C] in 6 [hp_C]
9/23/2025
Boiron
0220-0470
ORAL
10 [hp_M] in 10 [hp_M]
9/23/2025
Boiron
0220-0484
ORAL
6 [hp_X] in 1 1
9/23/2025
Newton Laboratories, Inc.
55714-2471
ORAL
15 [hp_X] in 1 mL
9/18/2025
Newton Laboratories, Inc.
55714-4748
ORAL
15 [hp_X] in 1 mL
8/20/2025
Natural Immunogenics Corp.dba SOVEREIGN NATURALS
52166-053
ORAL
10 [hp_X] in 1 mL
5/22/2025
Boiron
0220-0461
ORAL
12 [hp_C] in 12 [hp_C]
9/23/2025
Bray Group Limited
65875-101
TOPICAL
30 mg in 40 mg
7/18/2018
Teva Pharmaceuticals USA, Inc.
0093-9614
TOPICAL
0.005 g in 1 mL
11/6/2018
McKesson Medical-Surgical
68599-6302
TOPICAL
25 mg in 1 g
1/15/2021

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
Euphorbium compositum Nasal Spray
94405
Medicine
A
5/20/2003
Avoca Caustic Applicator 75% w/w Cutaneous Stick silver nitrate bag
278284
Sutherland Medical Pty Limited
Medicine
A
7/26/2016
SILVER NITRATE APPLICATORS
33738
Medicine
A
12/12/1991
Mucosa compositum N
124349
Medicine
A
12/19/2005
Allergy Oral Spray
351127
Medicine
A
12/8/2020

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
SILVER NITRATE LIQUID (S#106)-LIQ
total health centre
02193434
Liquid - Oral
6 X / ML
6/1/1997
ARGENTUM NITRICUM D6 (10 20 30) - LIQ
weleda ag heilmittelbetriebe
02121212
Liquid - Oral
6 D / ML
12/31/1995
HOMEO-FORM ST-LIQ
homeocan inc.
02140667
Liquid - Oral
9 X / ML
12/31/1995
HEEL 135 TAB
01969234
Tablet - Oral
6 D / TAB
12/31/1992
ACIDUM PHOSPHORICUM PLEX
seroyal international inc.
02233076
Pellet ,  Tablet ,  Drops ,  Syrup ,  Granules ,  Liquid - Oral
6 X
4/6/1998
ARGENTUM NITRICUM D6 LIQ
dr reckeweg canada
02038625
Liquid - Oral
6 D / ML
12/31/1993
PHOSPHOR-HOMACCORD
02229471
Drops - Oral
10 D / 100 ML
7/24/1997
HOMEODEX 02
distributions biodentcom inc.
02232208
Granules - Oral
15 CH
6/3/1998
HOMEO-FORM MI-TAB
homeocan inc.
02149362
Tablet - Oral
9 X
12/31/1995
MEDIPLEX 640 - LIQ
mediherb inc.
02116901
Liquid - Oral
10 X / ML
12/19/1996

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.